Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00685932 · ClinicalTrials.gov registry record · NA

Mobius® Post-cesarean Pain Randomized Control Trial

A NA study of Pregnancy and Complications; Cesarean Section, sponsored by Abbey Hardy-Fairbanks.

Completed
Registry status
NA
Development phase
154
Enrollment target
1
Study location

NCT00685932 is a NA study of Pregnancy and Complications; Cesarean Section that has completed, run by Abbey Hardy-Fairbanks. The registered enrollment target is 154 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00685932, a NA study of Pregnancy and Complications; Cesarean Section, has completed, sponsored by Abbey Hardy-Fairbanks.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate whether the use of the Mobius® retractor decreased post-operative pain after cesarean section verses conventional retractor use. Based on clinical experience and a pilot study, we suspect that the retractor will decrease overall pain as well as lateral pain.

Interventions

  • DEVICE Mobius Retractor

Study Locations (1)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2008-07
Est. Completion 2010-06
Phase NA

Sponsor

Abbey Hardy-Fairbanks

2 total trials

What the Registry Record Tells You About NCT00685932

The ClinicalTrials.gov registry entry for NCT00685932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (82% lower). The listed sponsor is Abbey Hardy-Fairbanks, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Mobius Retractor is the first listed.

NCT00685932 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT00685932 about?

NCT00685932 is a clinical study titled "Mobius® Post-cesarean Pain Randomized Control Trial". The purpose of this study is to investigate whether the use of the Mobius® retractor decreased post-operative pain after cesarean section verses conventional retractor use. Based on clinical experience and a pilot study, we suspect that the retractor will decrease overall pain as well as lateral pai...

What is the current status of trial NCT00685932?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2008-07. Estimated completion is 2010-06.

What conditions does trial NCT00685932 study?

This clinical trial studies the following conditions: Pregnancy, Complications; Cesarean Section.

What interventions are being tested in trial NCT00685932?

The interventions under investigation include: Mobius Retractor (DEVICE).

Who is sponsoring clinical trial NCT00685932?

This trial is sponsored by Abbey Hardy-Fairbanks, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00685932 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.